Does UKs Health & Safety Executive know that AstraZeneca's Vaxzevria is not being sold, but the supply chain is still active?
Control of Substances Hazardous to Health (COSHH) Regulations 2002 (as amended) apply
Yesterday, I posted this, with a promise of more to come
This is the next installment.
The document below was posted on the Government website:
SUMMARY OF PRODUCT CHARACTERISTICS: 1 NAME OF THE MEDICINAL PRODUCT - Vaxzevria, suspension for injection - COVID 19 Vaccine (ChAdOx1 S [recombinant])
If you worked in the NHS during COVID, or even if you have joined since, this is vitally important information for you. In summary, while AstraZeneca has stopped selling Vaxzevria, there is no assurance that potentially hazardous materials and products in its extensive supply chain are still out there.
The document states that “This product contains genetically modified organisms (GMOs).”
This is how the document begins (have you seen it previously?)
1 NAME OF THE MEDICINAL PRODUCT
Vaxzevria, suspension for injection. COVID 19 Vaccine (ChAdOx1 S [recombinant])
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One dose (0.5 ml) contains: COVID-19 Vaccine (ChAdOx1-S * recombinant), not less than 2.5 × 10 8 in…